Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CENSER: Early Norepinephrine in Septic Shock
NCT01945983Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Oct 2013
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of norepinephrine in septic shock, sepsis, sponsored by Mahidol University. Started Oct 2013; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on NCT01945983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945983.